FDA Inspection 1250797 — Zhejiang Langhua Pharmaceutical Co. Ltd.
The FDA completed an inspection of Zhejiang Langhua Pharmaceutical Co. Ltd. on Aug 30, 2024 in Linhai. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Aug 30, 2024
- Fiscal Year
- 2024
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Linhai (China)